Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

232
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
232
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

352
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
352

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carboxylic acid reductase-dependent biosynthesis of trans-anethole in engineered Escherichia coli.

Bioprocess and biosystems engineering·2026
Same author

De novo biosynthesis of τ-cadinol in engineered Escherichia coli.

Bioresources and bioprocessing·2024
Same author

De Novo Biosynthesis of 4-Vinylanisole in Engineered <i>Escherichia coli</i>.

Journal of agricultural and food chemistry·2024
Same author

De Novo Biosynthesis of Anisyl Alcohol and Anisyl Acetate in Engineered <i>Escherichia coli</i>.

Journal of agricultural and food chemistry·2023
Same author

De novo biosynthesis of N-acetyltyramine in engineered Escherichia coli.

Enzyme and microbial technology·2022
Same author

<i>De Novo</i> Biosynthesis of Methyl Cinnamate in Engineered <i>Escherichia coli</i>.

Journal of agricultural and food chemistry·2022

Related Experiment Video

Updated: Oct 21, 2025

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

18.7K

Biosynthesis of actarit using engineered Escherichia coli.

Daoyi Guo1, Xiao Fu1, Sijia Kong1

  • 1Key Laboratory of Organo-Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, Jiangxi Province, 341000, China.

Enzyme and Microbial Technology
|September 7, 2021
PubMed
Summary

Researchers engineered Escherichia coli to produce the rheumatoid arthritis drug actarit. This artificial biosynthetic pathway achieved a yield of 206 mg/L, paving the way for sustainable drug manufacturing.

Keywords:
ActaritEscherichia coliMetabolic engineeringN-acetyltransferase

More Related Videos

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
11:51

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence

Published on: April 27, 2018

12.1K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

10.0K

Related Experiment Videos

Last Updated: Oct 21, 2025

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

18.7K
Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
11:51

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence

Published on: April 27, 2018

12.1K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

10.0K

Area of Science:

  • Biotechnology
  • Synthetic Biology
  • Pharmacology

Background:

  • Rheumatoid arthritis is a chronic inflammatory disorder.
  • Actarit is an established therapeutic agent for rheumatoid arthritis.
  • No biosynthetic routes for actarit have been previously reported.

Purpose of the Study:

  • To develop the first artificial biosynthetic pathway for actarit.
  • To engineer Escherichia coli for actarit production.
  • To optimize actarit yield through metabolic engineering.

Main Methods:

  • Identification and characterization of an N-acetyltransferase for actarit synthesis.
  • Selection of 4-aminophenylacetic acid as a precursor.
  • Metabolic engineering of Escherichia coli, including overexpression of specific genes (ydiB and aroK).

Main Results:

  • Successful construction of an artificial actarit biosynthetic pathway in E. coli.
  • Demonstration of actarit production from simple carbon sources.
  • Achieved a significant production yield of 206 ± 16.9 mg/L.

Conclusions:

  • The study establishes a novel microbial platform for actarit biosynthesis.
  • Engineered E. coli offers a sustainable alternative for actarit production.
  • Metabolic engineering strategies effectively enhanced actarit yield.